CureSHANK Community News: APRIL 2026

This month, we’re seeing continued momentum across the PMS and SHANK3 community—from new therapeutic programs advancing toward the clinic to growing opportunities for collaboration at our upcoming 2026 Drug Development Symposium this April in New York City.

We’re also highlighting important community-driven efforts, including our first-ever PMS Burden of Illness Study, which aims to better understand and quantify the lived experience of families, alongside updates from recent research milestones and the incredible impact of Team CureSHANK at the L.A. Marathon.

Together, these efforts reflect the strength of this community and the progress we’re driving toward meaningful treatments.

As always, get the full story here.